Georgia Tech-developed vaccine exploits weaknesses of Leishmania parasite
A new experimental vaccine immunized genetically-altered mice from the Leishmania parasite, according to a recent study conducted by researchers from the Georgia Institute of Technology (Georgia Tech). With more than 30 different strains, Leishmania is classified at the world’s second-deadliest … Read More